Difficulty: Medium
Average Score: 94%
Testbank
A client with bipolar disorder has been taking lithium, and today his serum blood level is 1.8 mEq/L. The client reports nausea. Which of the following interventions by the nurse is indicated?
Correct answer
C
Rationale
C: Nausea
The client’s reported nausea is a common side effect of lithium toxicity, especially at a serum level of 1.8 mEq/L, which exceeds the therapeutic range typically considered safe (0.6 to 1.2 mEq/L).
A: Constipation and postural hypotension
While constipation and postural hypotension can occur with lithium use, they are not immediate signs of toxicity and do not directly relate to the client’s current symptoms of nausea.
B: Fever, muscle rigidity
Fever and muscle rigidity are indicative of neuroleptic malignant syndrome or severe lithium toxicity, which may occur at much higher serum levels. These symptoms are not relevant to the client's current presentation of nausea.
D: None, the serum level is in therapeutic range
This option is inaccurate as the serum level of 1.8 mEq/L is above the therapeutic range, indicating potential lithium toxicity, which can manifest as nausea.
The client’s reported nausea is a common side effect of lithium toxicity, especially at a serum level of 1.8 mEq/L, which exceeds the therapeutic range typically considered safe (0.6 to 1.2 mEq/L).
A: Constipation and postural hypotension
While constipation and postural hypotension can occur with lithium use, they are not immediate signs of toxicity and do not directly relate to the client’s current symptoms of nausea.
B: Fever, muscle rigidity
Fever and muscle rigidity are indicative of neuroleptic malignant syndrome or severe lithium toxicity, which may occur at much higher serum levels. These symptoms are not relevant to the client's current presentation of nausea.
D: None, the serum level is in therapeutic range
This option is inaccurate as the serum level of 1.8 mEq/L is above the therapeutic range, indicating potential lithium toxicity, which can manifest as nausea.